Romie Lane Dental Group, Inc. recently received ARESTIN® Certified Expert (ACE™) certification after completing comprehensive training on the diagnosis and treatment of Periodontitis.
United States of America (Press Release) August 13, 2007 --
Romie Lane Dental Group, Lewis H. Richardson, DDS, Inc. Receives Exclusive ACE™ Certification in the Diagnosis and Treatment of Periodontal Disease
Salinas, CA – August 9, 2007 – Romie Lane Dental Group, Lewis H. Richardson, DDS, Inc. recently received ARESTIN® Certified Expert (ACE™) certification after completing comprehensive training on the diagnosis and treatment of periodontal disease.
The exclusive ACE™ certification is important to residents of Salinas because periodontal disease is the most common chronic bacterial infection in adults, affecting 35.7 million Americans,1 and is the leading cause of adult tooth loss.2 In addition, the Surgeon General has issued a warning3 regarding the possible relationship between periodontal disease and a variety of medical conditions, including cardiovascular disease, diabetes, and osteoporosis.
“Knowing the negative impact periodontal disease that is left untreated can have on the oral heath and general health of my patients prompted me to enroll in the ACE™ certification training,” said Dr. Richardson. “This important and comprehensive periodontal disease diagnosis and treatment training program enables me to continue providing my patients with the highest standard of care available.”
ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg is a locally administered antibiotic (LAA) manufactured by OraPharma, Inc. Clinical studies have proven that ARESTIN® used as an adjunct to scaling and root planing (SRP) is more effective than SRP alone in eliminating periodontal pathogens.4
SRP is a manual procedure that is performed by a dentist or registered dental hygienist, whereby bacterial pathogens residing in the plaque and tartar are removed from below the gum line while smoothing the tooth’s root surfaces to promote healing and prevent plaque from again taking hold.
During SRP, many dentists prescribe or administer an LAA to treat the periodontal infection
and promote healing. One such LAA is OraPharma’s ARESTIN®. According to Dr. Richardson, “ARESTIN® is an effective antibiotic that kills the bacteria that cause periodontal disease.”
In order to earn ACE™ certification, Dr. Richardson was trained and tested in the following areas: accurate diagnosis of periodontal disease, effective treatment protocol, accurate insurance coding, the benefits of using LAAs, staff and patient education, encouraging patient compliance, patient monitoring, and the possible systemic health risks of untreated periodontal disease.
Salinas, CA – August 9, 2007 – Romie Lane Dental Group, Lewis H. Richardson, DDS, Inc. recently received ARESTIN® Certified Expert (ACE™) certification after completing comprehensive training on the diagnosis and treatment of periodontal disease.
The exclusive ACE™ certification is important to residents of Salinas because periodontal disease is the most common chronic bacterial infection in adults, affecting 35.7 million Americans,1 and is the leading cause of adult tooth loss.2 In addition, the Surgeon General has issued a warning3 regarding the possible relationship between periodontal disease and a variety of medical conditions, including cardiovascular disease, diabetes, and osteoporosis.
“Knowing the negative impact periodontal disease that is left untreated can have on the oral heath and general health of my patients prompted me to enroll in the ACE™ certification training,” said Dr. Richardson. “This important and comprehensive periodontal disease diagnosis and treatment training program enables me to continue providing my patients with the highest standard of care available.”
ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg is a locally administered antibiotic (LAA) manufactured by OraPharma, Inc. Clinical studies have proven that ARESTIN® used as an adjunct to scaling and root planing (SRP) is more effective than SRP alone in eliminating periodontal pathogens.4
SRP is a manual procedure that is performed by a dentist or registered dental hygienist, whereby bacterial pathogens residing in the plaque and tartar are removed from below the gum line while smoothing the tooth’s root surfaces to promote healing and prevent plaque from again taking hold.
During SRP, many dentists prescribe or administer an LAA to treat the periodontal infection
and promote healing. One such LAA is OraPharma’s ARESTIN®. According to Dr. Richardson, “ARESTIN® is an effective antibiotic that kills the bacteria that cause periodontal disease.”
In order to earn ACE™ certification, Dr. Richardson was trained and tested in the following areas: accurate diagnosis of periodontal disease, effective treatment protocol, accurate insurance coding, the benefits of using LAAs, staff and patient education, encouraging patient compliance, patient monitoring, and the possible systemic health risks of untreated periodontal disease.
Email
Print
SPAM
